Inventor
LYNN DOROTHY POULTON
Inventor
AU
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
PatentTitleYear
12,410,247Polynucleotides encoding antibodies that specifically bind to human IL-15202512,410,256Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases202512,162,946Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease202412,018,084Anti-CXCR2 antibodies and uses thereof202411,332,534Anti-CXCR2 antibodies and uses thereof202211,267,883Antibodies that specifically bind to human IL-15 and uses thereof202211,220,549Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to CEPHALON INC (3)· patent assignee history
2022–2025Based in AU· patent location history
2024–2025Patents assigned to CEPHALON LLC (4)· patent assignee history
2025Patents assigned to TEVA PHARMACEUTICALS AUSTRALIA PTY LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CEPHALON LLC | 4 | 2024–2025 |
| CEPHALON INC | 3 | 2022 |
| TEVA PHARMACEUTICALS AUSTRALIA PTY LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| AU | 7 | 2022–2025 |